Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 18th August 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA monitoring shortage of equine influenza vaccinations
"If it becomes necessary, we will collectively work to devise practical solutions for dealing with any supply difficulties" - Jim Eyre, CEO of British Equestrian.
Equine organisations preparing to quantify impact of interrupted supply.

A collaboration between the British Equine Veterinary Association (BEVA), British Equestrian (BEF) and the British Horseracing Authority (BHA) has been set up to monitor interruptions to the supply of equine influenza vaccines.

Minor interruptions to the supply of vaccines have already been noted by the group, but a significant logistical issue faced by Boehringer Ingelheim has further raised the likelihood of a reduction in supplies in the months ahead. 

The group is liaising with the three vaccine manufacturers to create solutions and minimise the impact of the shortage. 

Chair of BEVA's Health and Medicines Committee, David Rendle said: “BEVA, BHA and the BEF will continue to work together with other industry and equestrian sporting bodies to manage the situation should the availability of influenza vaccines be compromised further.

“We remind all horse owners of the importance of maintaining vaccination for equine influenza but would advise they wait until as close a time as possible until their horse’s next dose is due to minimise current demand.”

Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines. 

“This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue. This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market. 

“We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Germany livestock import ban lifted

The UK government has amended its ban on the import of livestock, meat and dairy products from Germany.

Defra said the decision follows 'rigorous technical assessment' of the measures applied and the current situation. "If the situation changes, we will not hesitate to take necessary action in response to the FMD outbreaks in the European Union to protect our domestic biosecurity," it said.

The ban was implemented in January following an outbreak of foot and mouth disease (FMD) near Berlin. Personal imports of meat, milk and dairy products will remain in place at a country level.